Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature.

Rachael A Vaubel, Selby G Chen, David R Raleigh, Michael J Link, Michael R Chicoine, Igor Barani, Sarah M Jenkins, Patrice Abell Aleff, Fausto J Rodriguez, Peter C Burger, Sonika Dahiya, Arie Perry, Caterina Giannini
{"title":"Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature.","authors":"Rachael A Vaubel, Selby G Chen, David R Raleigh, Michael J Link, Michael R Chicoine, Igor Barani, Sarah M Jenkins, Patrice Abell Aleff, Fausto J Rodriguez, Peter C Burger, Sonika Dahiya, Arie Perry, Caterina Giannini","doi":"10.1093/jnen/nlv006","DOIUrl":null,"url":null,"abstract":"<p><p>The behavior of rhabdoid meningiomas otherwise lacking malignant features remains unknown as most of the originally reported aggressive cases showed anaplastic histologic features independently of rhabdoid phenotype. We studied 44 patients with rhabdoid meningiomas lacking anaplastic features. Median age at diagnosis was 48.6 years (range 10-79). Location was supratentorial in 28 (63.6%), skull base in 15 (34.1%), and spinal in 1 (2.3%). Tumor grade was otherwise World Health Organization grade I (n = 22, 50%) or II (n = 22, 50%). Rhabdoid cells represented <20% of the tumor in 12 cases (27.3%), 20% to 50% in 18 (40.9%), and >50% in 14 (31.8%). Median clinical follow-up, available for 38 patients, was 5.0 years (range 0.17-14.2). Recurrence occurred in 9 patients (5-year recurrence-free survival, 73.7%) with a significantly higher risk in subtotally resected tumors (p = 0.043). Rhabdoid cell percentage was not associated with recurrence. Six patients died (4 of disease, 2 of unclear causes); 5-year overall survival was 86.7%, a mortality in excess of that expected in grade I-II meningiomas but much lower than originally reported. Review of 50 similar previously reported cases confirmed our findings. We suggest that rhabdoid meningiomas be graded analogously to nonrhabdoid tumors, with caution that some may still behave aggressively and close follow-up is recommended. </p>","PeriodicalId":16434,"journal":{"name":"Journal of Neuropathology & Experimental Neurology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009417/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuropathology & Experimental Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jnen/nlv006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2015/12/7 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The behavior of rhabdoid meningiomas otherwise lacking malignant features remains unknown as most of the originally reported aggressive cases showed anaplastic histologic features independently of rhabdoid phenotype. We studied 44 patients with rhabdoid meningiomas lacking anaplastic features. Median age at diagnosis was 48.6 years (range 10-79). Location was supratentorial in 28 (63.6%), skull base in 15 (34.1%), and spinal in 1 (2.3%). Tumor grade was otherwise World Health Organization grade I (n = 22, 50%) or II (n = 22, 50%). Rhabdoid cells represented <20% of the tumor in 12 cases (27.3%), 20% to 50% in 18 (40.9%), and >50% in 14 (31.8%). Median clinical follow-up, available for 38 patients, was 5.0 years (range 0.17-14.2). Recurrence occurred in 9 patients (5-year recurrence-free survival, 73.7%) with a significantly higher risk in subtotally resected tumors (p = 0.043). Rhabdoid cell percentage was not associated with recurrence. Six patients died (4 of disease, 2 of unclear causes); 5-year overall survival was 86.7%, a mortality in excess of that expected in grade I-II meningiomas but much lower than originally reported. Review of 50 similar previously reported cases confirmed our findings. We suggest that rhabdoid meningiomas be graded analogously to nonrhabdoid tumors, with caution that some may still behave aggressively and close follow-up is recommended.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
缺乏其他恶性肿瘤组织学特征的横纹肌瘤:44 个病例的研究和文献综述。
由于最初报道的侵袭性病例大多表现为无弹性组织学特征,而非横纹表型,因此缺乏恶性特征的横纹状脑膜瘤的表现仍然未知。我们对 44 例缺乏无弹性特征的横纹肌脑膜瘤患者进行了研究。确诊时的中位年龄为48.6岁(10-79岁不等)。肿瘤位置为胸膜上28例(63.6%)、颅底15例(34.1%)和脊柱1例(2.3%)。肿瘤分级为世界卫生组织I级(22例,50%)或II级(22例,50%)。14例(31.8%)中横纹肌细胞占50%。38名患者的中位临床随访时间为5.0年(0.17-14.2年不等)。9名患者出现复发(5年无复发生存率为73.7%),次全切除肿瘤的复发风险明显更高(P = 0.043)。横纹肌细胞百分比与复发无关。6名患者死亡(4人死于疾病,2人死因不明);5年总生存率为86.7%,死亡率超过了I-II级脑膜瘤的预期,但比最初报道的要低得多。对之前报道的 50 例类似病例的回顾证实了我们的研究结果。我们建议对横纹肌脑膜瘤进行类似于非横纹肌脑膜瘤的分级,但要注意有些肿瘤仍可能具有侵袭性,建议进行密切随访。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Stirling Carpenter, MD February 27, 1929–February 19, 2021 William G. Ellis, MD June 12, 1932–January 16, 2021 Autobiography Series: A Life of Anecdotes Meritorious Contributions to Neuropathology In Memoriam: Carol Petito, MD
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1